← Back to patent-cliff list
CAS 1613638-20-2
sodium (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)acrylate
Codes: Pyragrel Sodium
Application context (from source-drug indications)
Cerebral infarctionPyragrel Sodium运动障碍Pyragrel Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Pyragrel Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid→ethyl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate→2-(chloromethyl)-3,5,6-trimethylpyrazine→ethyl (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)acrylate→sodium (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)acrylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.